Ashwin Athri, Executive Vice President at PRECISIONxtract said, “This capability will enable Precision to continue to build upon its best-in-class suite of data integration products that solve for the payer, provider, and now patient dimensions. This partnership complements our existing data assets, and allows us to knit together data for our customers, unlock enhanced insights, power more significant interactions across all stakeholders, and advance our ability to assess the value for new and emerging innovative therapies.”
“Solving the data fragmentation challenge is key to ensuring that life science organizations can deliver the right therapy to the right patient at the right time,” said Travis May, Founder and Chief Executive Officer of Datavant. “We are excited for this partnership and to further support Precision in delivering richer insights to their clients.”
Datavant’s mission is to connect the world’s health data to improve patient outcomes. Datavant works to reduce the friction of data sharing across the healthcare industry by building technology that protects the privacy of patients while supporting the linkage of de-identified patient records across datasets. Datavant is headquartered in San Francisco. Learn more about Datavant at www.datavant.com
PRECISIONxtract transforms biopharmaceutical company commercialization with innovative data management solutions, predictive multistakeholder analytics, and dynamic customer engagement solutions. We empower data-driven insights, enable better promotion decisions, and equip richer customer engagements through our Commercial Data Management Solutions, Customer Engagement Solutions, and expert Analytic Consulting teams.
Contact us at firstname.lastname@example.org.
Louis Landon, Precision Medicine Group Media Relations
Sarah Rowe, Head of Marketing